Cyclin D1 promotes tumor cell invasion and metastasis by cytoplasmic mechanisms

Noel P Fusté1, Francisco Ferrezuelo1, Eloi Garí1

  • 1Cell Cycle laboratory, Institut de Recerca Biomèdica de Lleida (IRB Lleida), and Departament de Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida, Lleida, Catalonia, Spain; Departament de Ciencies Mediques Basiques, Facultat de Medicina, Universitat de Lleida, Lleida, Catalonia, Spain.

Insights

Cyclin D1 amplification is common in many cancers. This study reveals how cyclin D1-CDK4 complexes regulate tumor invasion and metastasis by activating RAC1 via paxillin phosphorylation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cyclin D1 amplification is a frequent event in diverse cancer types.
  • Cyclin D1 plays a role in regulating tumor invasion and metastasis.
  • The precise molecular mechanisms linking cyclin D1 to cancer progression are under investigation.

Purpose of the Study:

  • To elucidate the novel regulatory axis involving cyclin D1 in tumor invasion and metastasis.
  • To investigate the role of cyclin D1-CDK4 complexes in activating the small GTPase RAC1.
  • To determine the involvement of paxillin phosphorylation in this pathway.

Main Methods:

  • Investigated the role of cyclin D1 in cancer progression.
  • Utilized molecular biology techniques to study protein interactions and phosphorylation events.
  • Focused on the cyclin D1-CDK4 complex and its downstream targets.

Main Results:

  • Identified a novel regulatory pathway where cyclin D1 is involved in tumor invasion and metastasis.
  • Demonstrated that membrane-associated cyclin D1-CDK4 complexes activate the small GTPase RAC1.
  • Showed that this activation occurs through the phosphorylation of the regulatory protein paxillin.

Conclusions:

  • Cyclin D1, through its association with CDK4, directly influences tumor cell invasive and metastatic potential.
  • The phosphorylation of paxillin by cyclin D1-CDK4 complexes is a key step in activating RAC1.
  • This pathway represents a potential therapeutic target for inhibiting cancer spread.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K